1. [1] M. P. Leze, M. Le Borgne, P.Pinson, A. Palusczak, M. Duflos, G. LeBaut,and R. W. Hartmann,2- and 3-[(aryl)(azolyl)methyl]indoles as potential non-steroidal aromatase inhibitors, Bioorg. Med. Chem. Lett. 1134(2004)549-557.
2. [2] L. A. Torre, F. Islami, R. L. Siegel, E. M. Ward, et A. Jemal,Global Cancer in Women: Burden and Trends, Cancer Epidemiology and Prevention Biomarkers 26 (2017) 444 57.
3. [3] P. P. Koonings, K.Campbell, D. R. J. Mishell,and D. A.Grimes,Global Cancer in Women: Burden and Trends , Obstet. Gynecol.74,(1989) 921-926.
4. [4] M. J. Reed, The role of aromatase in breast tumors, Breast Cancer Res. Treat. 30, (1994) 7-17.
5. [5] E. R. Simpson, M. S. Mahendroo, G. D.Means, M. W.Kilgore, M. M.Hinshelwood, S. Graham-Lorence, B.Amarneh,Y.Ito, C. R. Fisher, andM. D. Michael, Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis, Endocr. Rev.15 (1994) 342-355.